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Objective: To investigate cross-sectional and predictive associations of plasma adipokines with
biochemical markers of systemic joint metabolism and radiographic signs of early-stage knee osteoar-
thritis (OA).
Design: The adipokines pLeptin, pAdiponectin, and pResistin, the cartilage markers C-terminal telopep-
tide of type II collagen (uCTX-II), N-terminal propeptide of type IIA procollagen (sPIIANP), chondroitin
sulfate 846 (sCS846), and cartilage oligomeric matrix protein (sCOMP), and the synovial markers hya-
luronic acid (sHA) and N-terminal propeptide of type III procollagen (sPIIINP) were assessed by enzyme-
linked immunosorbent assay or radioactive immunoassay in baseline samples of Cohort Hip and Cohort
Knee (CHECK), a cohort of 1002 subjects with early-stage symptomatic knee and/or hip OA. Knee
radiographs were obtained at baseline and after 2 and 5 years and scored according to Kellgren &
Lawrence.
Results: pLeptin showed positive associations with uCTX-II, sCOMP, sPIIANP, sHA, and sPIIINP, and with
presence and progression of radiographic knee OA. Associations expectedly disappeared after adjustment
for body mass index. pResistin showed positive associations with sPIIINP and present and incident
radiographic knee OA that were largely independent of BMI. pAdiponectin showed positive associations
with uCTX-II and sCOMP. Furthermore, pAdiponectin did not show associations with radiographic knee
OA on itself, but associations of pResistin with present radiographic knee OA were stronger in higher
pAdiponectin tertiles (P ¼ 0.024 for interaction between pAdiponectin and pResistin). Although statis-
tically signiﬁcant, all associations were weak.
Conclusions: Adipokines may have aggravating, although may be minor, structural effects in early-stage
knee OA.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) of the knee is among the most common
disabling diseases in the developed world. Aging of the population
and the ongoing obesity epidemic will probably cause theW.E. Van Spil, Department of
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s Research Society International. Pprevalence of knee OA to rise even more in the nearby future1.
Obesity has received much scientiﬁc interest as one of the well-
recognized and modiﬁable causes of this rising OA burden.
Although the association between obesity and knee OA has classi-
cally been attributed to biomechanical mechanisms, more recently
also humoral mechanisms have been implied since body mass
index (BMI) appeared to be involved in hand OA also2. Key medi-
ators in this metabolic link between obesity and OA could be the
adipokines (leptin, adiponectin, resistin, and others) that are
among the many cytokines secreted by adipose tissue. Although
a plethora of in vitro and ex vivo studies on adipokines and joint
metabolism are available, only a limited number of mainly small
clinical studies on systemic adipokines in knee OA have been
performed.ublished by Elsevier Ltd. All rights reserved.
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currently available studies on (knee) OA. Anandacoomarasamy et al.
assessed Delayed Gadolinium-Enhanced Magnetic Resonance
Imaging of Cartilage (dGEMRIC) indexes of knee cartilage to assess
glycosaminoglycan distribution in 77 obese individuals with and
without clinical knee OA. dGEMRIC indexes were negatively asso-
ciated with aging, presence of clinical knee OA, and higher serum
leptin levels3. On the other hand, Iwamoto et al. investigated
50 postmenopausal women with knee OA and did not ﬁnd any
association between serum leptin levels and Kellgren & Lawrence
(K&L) grade4. Interestingly, Berry et al. did not ﬁnd an association
between baseline serum leptin levels and 2-year changes of carti-
lage volume and defects in 117 knee OA subjects fulﬁlling clinical
and radiographic ACR-criteria. They, however, did ﬁnd that serum
levels of the soluble leptin receptor, which supposedly serves to
decrease leptin activity, protected against loss of cartilage volume
and progression of cartilage defects5. Studies on adiponectin in
knee OA are inconsistent. Honsawek et al. reported on an inverse
association between plasma adiponectin levels and maximum K&L
grade of both knees in 76 knee OA patients that disappeared after
adjustment for demographics6. As opposed to this study, Koskinen
et al. investigated 30 male presurgical knee OA patients and found
increased plasma adiponectin levels in (radiographic) Ahlbäck
grade 4-5 as compared to less severely affected subjects7. Moreover,
Berry et al. did not ﬁnd any association between baseline adipo-
nectin and resistin levels and 2-year changes of cartilage volume
and defects in the aforementioned study in knee OA subjects5. To
the best of our knowledge, no other studies on systemic resistin
levels and knee OA exist yet. In a study on hand OA by Yusuf et al.
serum resistin levels were not statistically signiﬁcantly associated
with radiographic progression8, nor were they increased in 48
womenwith erosive hand OA as compared to 27 womenwith non-
erosive disease in a study by Filková et al.9
In the current study in 1002 subjects with early-stage symp-
tomatic knee and/or hip OA, plasma adipokines were investigated
for potential relations with joint metabolism and OA. First, they
were tested for cross-sectional associations with systemic
biochemical markers of cartilage and synovial metabolism to
explore associations between plasma adipokines and systemic joint
metabolism in general. Furthermore, they were tested for cross-
sectional and predictive associations with radiographic knee OA.
The role of BMI in these associations was speciﬁcally highlighted,
since systemic adipokines have been suggested to function as
mediators between adipose tissue and joint metabolism and OA.
Method
Cohort characteristics
Cohort Hip and Cohort Knee (CHECK) is a running 10-year
prospective multi-center cohort study of 1002 subjects, age
45e65 years, with pain and/or stiffness of one and/or both
knee(s) and/or hip(s)10. They had never or not longer than
6 months ago consulted a physician for these symptoms for the
ﬁrst time. Subjects with any clear other pathological condition
that could explain the symptoms (e.g., other rheumatic disease,
previous hip or knee joint replacement, congenital dysplasia)
were excluded. CHECK is conducted according to the declaration
of Helsinki (as revised in 2000) and received approval from the
ethics committee of each of the involved medical centers.
Biochemical markers
Adipokines and biomarker levels were assessed in baseline
plasma, serum, and urine samples from CHECK. Plasma (p), serum(s), and second morning void urine (u) samples were collected in
a non-fasted state, between 8 and 12 AM. Adipokines and
biomarkers were assessed by enzyme-linked immunosorbent assay
or radioactive immunoassay, according to manufacturer instruc-
tions, as was described previously. Intra-plate, inter-plate, and
between-day coefﬁcients of variation [standard deviation (SD)/
mean 100%] were as follows: pLeptin (BioVendor, Modrice, Czech
Republic): 7.8, 5.7, and 7.0%. pAdiponectin (BioVendor, Modrice,
Czech Republic): 18.9, 14.3, and 9.0%. pResistin (BioVendor, Mod-
rice, Czech Republic): 7.1, 3.9, and 2.5%. C-terminal telopeptide of
type II collagen (uCTX-II; Urine Cartilaps EIA, Immunodiagnostic
Systems Ltd., Boldon, UK): 10.0%, 9.3%, and 12.4%. Cartilage oligo-
meric matrix protein (sCOMP; Anamar Med AB, Göteborg,
Sweden): 5.0%, 4.0%, and 4.2%. Type IIA collagen N-propeptide
(sPIIANP; Millipore Corp, Billerica, MA, US): 15.8%, 7.0%, and 15.7%.
Chondroitin sulfate 846 (sCS846; IBEX, Montreal, Canada): 21.5%,
16.9%, and 15.3%. Hyaluronic acid (sHA; Corgenix Inc, Westminster,
CO, US): 15.1%, 13.0%, and 17.3%. Type III collagen N-propeptide
(sPIIINP; UniQ, Orion Diagnostica, Espoo, Finland): 5.4%, 3.2%, and
7.2%. Urinary biomarker levels were adjusted for urinary creatinine
concentrations (automated kinetic assay, UniCel DxC 800 Syn-
chron Clinical System, Beckman Coulter).
For pLeptin and pAdiponectin, 41 and nine samples showed
plasma levels above standard curves, respectively. For Leptin, these
high levels were especially observed for female subjects with
higher BMI. For these samples adipokine levels were arbitrarily set
at 120% of the maximum level that was assessed in samples inside
standard curves as was described previously11. Conclusions did not
differ essentially between analyses with and without these arbi-
trarily set levels.
Radiographic data acquisition and deﬁnitions
For the present study, only radiographic knee OA was evaluated
since associations with BMI are more apparent for knee than for hip
OA12,13. Knee radiography was performed at baseline and after
2 and 5 years. Radiographs of the tibiofemoral joints were made in
a weight-bearing posteroanterior view, semiﬂexed (7e10 degrees).
They were scored by ﬁve trained observers according to K&L 14, in
a paired fashion, with known sequence. The examiners were
extensively trained by a musculoskeletal radiologist and an expe-
rienced reader. A random subset of radiographs of 38 participants
was read by all observers, independently of each other, yielding
moderate to substantial inter-observer agreement (Kappa 0.60 for
presence of K&L grade2 in the knees at 5-year follow-up).
Present radiographic knee OA at baseline was necessarily
deﬁned as K&L grade ¼ 1, since maximum baseline K&L grade ¼ 1,
in accordance with the early-stage OA in CHECK subjects.
Incidence of radiographic knee OA was investigated in those
subjects that did not show radiographic knee OA at baseline (K&L
grade ¼ 0 for the left and right knee). Incidence was deﬁned as an
increase of 1 K&L grade for the left and/or right knee, which was
again considered most appropriate in this early-stage OA cohort. In
addition, the extent of incident knee OA was quantiﬁed as the area
under the curve (AUC) of the summed K&L grade of the left and
right knee between baseline and 5 years. The AUC was calculated
according to the formula: [(summed K&L grade at 2 years
minus baseline) 2  0.5 þ (summed K&L grade at 5 years minus
2 years) 3  0.5 þ (summed K&L grade at 2 years minus
baseline) 3].
Radiographic knee OA progression was investigated in those
subjects that did show radiographic knee OA at baseline already
(K&L grade ¼ 1 for the left and/or right knee). Progression in
these subjects was deﬁned as an increase of 1 K&L grade for the
left and/or right knee. In addition, the extent of this progression
Table I
Overview of baseline demographics of CHECK subjects and availability of
biochemical and radiographic data. Data are presented as median (25e75%
percentiles), unless stated otherwise
Baseline demographics
(1002 subjects)
Female 79.0%
Age (mean  SD) 56  5 years
BMI 25.5 (23.3e28.4) kg/m2
Adipokines, data available
(981 subjects, 97.9% of 1002)
pLeptin 11.3 (6.2e19.4) ng/ml
pAdiponectin 9.8 (7.3e14.0) mg/ml
pResistin 3.5 (3.0e4.3) ng/ml
Biomarkers of joint metabolism
(>960 subjects, 95.8% of 1002)
uCTX-II 193 (132e281) ng/mmol
sCOMP 8.5 (7.2e9.9) U/l
sPIIANP 1385 (1087e1771) ng/ml
sCS846 70 (54e88) ng/ml
sHA 27 (17e43) ng/ml
sPIIINP 4.1 (3.5e4.9) ng/ml
Radiographic data for those subjects with complete adipokine data:
Present knee OA at baseline
850 subjects, 84.8% of 1002
Radiographic knee OA Number of subjects (% of total)
No 414 (48.7%)
Unilateral 210 (24.7%)
Bilateral 226 (26.6%)
Knee OA incidence subcohort
387 subjects, 93.5% of 414 subjects without OA at baseline
AUC of summed K&L grades Number of subjects (% of total)
0 253 (65.4%)
1.5 36 (9.3%)
2.5 2 (0.5%)
3 14 (3.6%)
4 34 (8.8%)
4.5
5.5 24 (6.2%)
7 3 (0.8%)
8 16 (4.1%)
9.5 5 (1.3%)
Knee OA progression subcohort
410 subjects, 94.0% of 436 subjects with OA at baseline
AUC of summed K&L grades Number of subjects (% of total)
0 141 (34.4%)
1.5 57 (13.9%)
2.5 2 (0.5%)
3 8 (2.0%)
4 73 (17.8%)
4.5 3 (0.7%)
5 1 (0.2%)
5.5 30 (7.3%)
6 1 (0.2%)
6.5 2 (0.5%)
7 9 (2.2%)
8 59 (14.4%)
8.5 1 (0.2%)
9.5 10 (2.4%)
11 2 (0.5%)
12 5 (1.2%)s
13.5 6 (1.5%)
CTX-II, C-terminal telopeptide of type II collagen; PIIANP, N-terminal pro-
peptide of type IIA procollagen; CS846, chondroitin sulfate 846; PIIINP,
N-terminal propeptide of type III procollagen.
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between baseline and 5 years.
Statistical analysis
Cross-sectional associations between adipokine (independent
variables) and biomarker levels (dependent variables) were inves-
tigated by linear regression.
Cross-sectional associations between plasma adipokine levels
(independent variables) and presence of radiographic knee OA
(dependent variable) at baseline were investigated by binary
logistic regression. Subsequently, in subjects with radiographic
knee OA it was determined whether adipokine levels (independent
variables) were different between subjects with unilateral and
bilateral radiographic knee OA (dependent variable) by binary
logistic regression.
Baseline adipokine levels (independent variables) were
compared between subjects that did and did not show incidence or
progression of radiographic knee OA during the 5-year follow-up
(dependent variables) by binary logistic regression. In those
subjects showing any radiographic knee OA incidence or progres-
sion during 5-year follow-up, associations between adipokine
levels (independent variables) and the extent of this incidence and
progression (i.e., AUC of summed K&L grade progression, depen-
dent variables) were investigated by linear regression.
pLeptin and pResistin were positively associated with high-
sensitivity C-reactive protein (hsCRP) levels (standardized regres-
sion coefﬁcient¼ 0.375 and 0.239, P< 0.001 for both, respectively),
while pAdiponectin was negatively associated with hsCRP levels
(standardized regression coefﬁcient ¼ 0.247, P < 0.001) (data not
shown). Therefore, interaction between these apparently pro-
inﬂammatory and anti-inﬂammatory adipokines in their associa-
tions with radiographic knee OA was investigated. Statistically
signiﬁcant interaction (P < 0.1) between two adipokines indicates
that the effect of the one adipokine on the outcome is dependent on
the level of the second adipokine.
Geometric adipokine and biomarker levels were logarithmically
transformed and the square root of the AUC was used to obtain
normally distributed variables, and thereby residuals, whenever
necessary. To speciﬁcally address the involvement of BMI in the
associations between adipokines and outcomes, associations were
ﬁrst adjusted for gender and age only and in a next step for BMI
also.
To facilitate direct comparison between regression coefﬁcients
of variables andmodels obtained by linear regression, standardized
regression coefﬁcients are presented. Standardized regression
coefﬁcients represent the number of SDs that the outcome will
change as a result of one SD change in the predictor and are
therefore independent of the units of measurement of the variables
and can vary between 1 and 1. Unadjusted standardized regres-
sion coefﬁcients are identical to Pearson’s correlation coefﬁcients.
All statistical analyses were performed using SPSS, version 15.0.
Statistical signiﬁcance was deﬁned as P values<0.05, except P< 0.1
for interaction terms.
Results
Baseline characteristics of CHECK subjects are shown in Table I
as are the numbers of subjects for whom biochemical and radio-
graphic data were available.
Adipokines and biomarkers of joint metabolism
Plasma adipokine levels showed associations with biomarkers
of systemic joint metabolism to a variable extent, as is shown inTable II. After adjustment for gender and age, pLeptinwas positively
associated with the cartilage markers uCTX-II, sCOMP, and sPIIANP,
and synovial markers sHA and sPIIINP. All these associations dis-
appeared after (additional) adjustment for BMI, except for the
positive associations with sPIIANP and sPIIINP that persisted to
a lesser extent. pAdiponectin showed positive associations with
Table II
Associations of plasma adipokine levels with serum and urinary biomarker levels. Standardized regression coefﬁcients (stand coeff), 95% conﬁdence intervals (95% CI), and P
values as obtained by linear regression are reported. Unadjusted associations were consecutively adjusted for age and gender and for BMI
Dependent Independent
pLeptin pAdiponectin pResistin
Unadjusted Adjusted for
age, gender
þBMI Unadjusted Adjusted for
age, gender
þBMI Unadjusted Adjusted for
age, gender
þBMI
Cartilage
uCTX-II Stand coeff 0.173 0.102 0.008 0.146 0.062 0.099 0.035 0.030 0.003
95% CI 0.110e0.236 0.030e0.174 0.095e0.112 0.083e0.209 0.002e0.126 0.033e0.166 0.029e0.098 0.030e0.091 0.058e0.065
P <0.001 0.005 0.872 <0.001 0.058 0.004 0.283 0.327 0.917
sCOMP Stand coeff 0.008 0.138 0.025 0.062 0.098 0.150 0.043 0.030 0.054
95% CI 0.055e0.072 0.066e0.211 0.129e0.079 0.001e0.125 0.033e0.163 0.082e0.214 0.107e0.020 0.092e0.031 0.115e0.008
P 0.793 <0.001 0.636 0.055 0.003 <0.001 0.179 0.332 0.088
sPIIANP Stand coeff 0.148 0.162 0.142 0.008 0.042 0.019 0.016 0.015 0.001
95% CI 0.086e0.211 0.088e0.237 0.035e0.252 0.071e0.056 0.109e0.025 0.090e0.051 0.047e0.080 0.049e0.078 0.066e0.063
P <0.001 <0.001 0.010 0.816 0.216 0.585 0.611 0.647 0.970
sCS846 Stand coeff 0.037 0.053 0.032 0.015 0.011 0.010 0.003 0.002 0.004
95% CI 0.026e0.101 0.022e0.129 0.077e0.142 0.078e0.049 0.079e0.056 0.060e0.081 0.060e0.066 0.061e0.066 0.069e0.060
P 0.248 0.167 0.559 0.650 0.741 0.772 0.925 0.943 0.896
Synovium
sHA Stand coeff 0.032 0.115 0.026 0.032 0.009 0.048 0.009 0.004 0.013
95% CI 0.031e0.096 0.045e0.185 0.073e0.125 0.032e0.095 0.054e0.071 0.016e0.111 0.073e0.054 0.055e0.063 0.071e0.046
P 0.323 0.001 0.607 0.329 0.789 0.144 0.776 0.901 0.676
sPIIINP Stand coeff 0.179 0.279 0.151 0.025 0.023 0.038 0.127 0.130 0.099
95% CI 0.117e0.242 0.206e0.352 0.046e0.259 0.089e0.038 0.090e0.044 0.031e0.107 0.064e0.190 0.067e0.193 0.036e0.162
P <0.001 <0.001 0.005 0.431 0.502 0.278 <0.001 <0.001 0.002
CTX-II, C-terminal telopeptide of type II collagen; PIIANP, N-terminal propeptide of type IIA procollagen; CS846, chondroitin sulphate 846; PIIINP, N-terminal propeptide of
type III procollagen.
The bold value represents statistically signiﬁcant associations (P < 0.05)
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turned somewhat stronger after adjustment for BMI. pResistin was
positively associated with sPIIINP only. This association was not
evidently dependent of BMI as it only slightly decreased
after adjustment for BMI. Although statistically signiﬁcant, all
these associations were weak (maximum standardized regression
coefﬁcient ¼ 0.279).
Adipokines and radiographic knee OA
Associations between baseline plasma adipokine levels and
presence, incidence, and progression of radiographic knee OA are
shown in Fig. 1 and Table III.
pLeptin appeared to be positively associated with presence of
radiographic knee OA [odds ratio (OR)/unit ¼ 1.016, P < 0.001,
unadjusted]. Moreover, pLeptinwas positively associatedwith knee
OA progression in subjects having radiographic knee OA at baseline
(OR ¼ 1.020, P ¼ 0.005, unadjusted). As was observed for the
biochemical markers, these associations disappeared only after
(additional) adjustment for BMI. pLeptin was not associated with
incidence of radiographic knee OA in subjects without radiographic
knee OA at baseline.
None of the associations between pAdiponectin and presence,
incidence, and progression of radiographic knee OA were statisti-
cally signiﬁcant.
pResistin showed a positive association with presence of
radiographic knee OA (OR/unit ¼ 1.222, P ¼ 0.001, unadjusted).
Furthermore, pResistin was positively associated with incidence of
radiographic knee OA in subjects without OA at baseline (OR/
unit ¼ 1.261, P ¼ 0.015, unadjusted). As was observed for the
biochemical markers, these associations between pResistin and
radiographic knee OA were independent of demographic variables
including BMI. pResistin was not associated with progression of
radiographic knee OA.
Although pLeptin and pResistin were associated with presence
of radiographic OA in either one or both knees, none of theadipokines were different between subjects with unilateral and
bilateral radiographic knee OA. Likewise, pLeptin and pResistin
were associated with occurrence of radiographic knee OA
progression and incidence during follow-up, respectively, but none
of them were associated with their extent [Fig. 1].
Inﬂammation as mediator between adipokines and radiographic
knee OA
To investigate whether the associations of pLeptin and pResistin
with radiographic knee OA could be mediated by inﬂammation,
hsCRP and ESR were tested as confounders of these associations.
This, however, was not the case for any of them (data not shown).
Interaction between adipokines
No statistically signiﬁcant interaction between adipokines in
their associations with radiographic knee OA was observed, except
for pResistin and pAdiponectin showing interaction in their asso-
ciation with presence of radiographic knee OA (P ¼ 0.024, other
data not shown). When the association of pResistin with presence
of radiographic knee OA was tested per pAdiponectin quartile, it
appeared that the positive association of pResistinwith presence of
radiographic knee OAwas observed in the two upper pAdiponectin
quartiles only [Fig. 2]. pAdiponectin did not show an association
with presence of radiographic knee OA in any pResistin quartile,
nor was a gradient between quartiles observed (data not shown).
Discussion
This is the ﬁrst large-scale, 5-year cohort study on systemic
adipokines in (very) early-stage knee OA. Leptin showed the most
statistically signiﬁcant associations with systemic biomarkers of
cartilage and synovial metabolism and showed positive associa-
tions with presence and progression of radiographic knee OA.
These associations largely disappeared after adjustment for BMI.
Fig. 1. Boxplots showing unadjusted associations between plasma leptin and resistin levels and presence, incidence, and progression of radiographic knee OA. Associations with
plasma adiponectin were not statistically signiﬁcant and are not shown here. For the sake of clarity outliers (>1.5  interquartile range from the rest of the scores) are not displayed,
but were included in all statistical analyses. The AUC of progression of summed K&L grade of the left and right knee is categorized in these boxplots, but was used non-categorized in
all analyses (see Table I). Statistically signiﬁcant associations (P < 0.05) are in bold.
Table III
Associations between plasma adipokine levels and radiographic knee OA (a) presence, (b) incidence, and (c) progression. Radiographic knee OA was deﬁned as K&L grade 1
for the left and/or right knee. Incident radiographic knee OAwas deﬁned as occurrence of radiographic knee OA during follow-up in subjects without radiographic knee OA at
baseline yet. Radiographic knee OA progression was deﬁned as an increase of K&L grade 1 in one or both knees of subjects with radiographic knee OA at baseline already.
Associations were investigated by binary logistic regression, and consecutively adjusted for summed K&L grade for the left and right knee at baseline (progression only), age
and gender, and ﬁnally BMI. Statistically signiﬁcant associations (P < 0.05) are in bold
Unadjusted Adjusted for age, gender þBMI
OR/unit (95% CI) P OR/unit (95% CI) P OR/unit (95% CI) P
(a) Presence of radiographic knee OA
pLeptin 1.016 (1.007e1.025) <0.001 1.016 (1.006e1.025) 0.001 1.002 (0.990e1.015) 0.705
pAdiponectin 0.999 (0.979e1.019) 0.923 0.991 (0.970e1.012) 0.391 1.000 (0.978e1.023) 0.978
pResistin 1.222 (1.084e1.379) 0.001 1.219 (1.080e1.377) 0.001 1.169 (1.033e1.322) 0.013
(b) Occurrence of incident knee OA
pLeptin 0.998 (0.983e1.014) 0.837 0.994 (0.978e1.011) 0.470 1.005 (0.984e1.026) 0.656
pAdiponectin 1.030 (0.999e1.062) 0.059 1.027 (0.995e1.061) 0.103 1.021 (0.987e1.056) 0.228
pResistin 1.261 (1.046e1.520) 0.015 1.254 (1.040e1.511) 0.018 1.285 (1.061e1.556) 0.010
Unadjusted Adjusted for baseline knee OA þAge, gender þBMI
OR/unit (95% CI) P OR/unit (95% CI) P OR/unit (95% CI) P OR/unit (95% CI) P
(c) Occurrence of knee OA progression
pLeptin 1.020 (1.006e1.034) 0.005 1.020 (1.006e1.034) 0.004 1.018 (1.004e1.033) 0.013 1.001 (0.986e1.026) 0.590
pAdiponectin 1.006 (0.976e1.038) 0.684 1.006 (0.975e1.037) 0.725 0.999 (0.967e1.032) 0.951 1.011 (0.978e1.046) 0.511
pResistin 1.039 (0.874e1.235) 0.664 1.037 (0.873e1.233) 0.680 1.029 (0.865e1.224) 0.749 0.986 (0.823e1.181) 0.880
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Fig. 2. Column bar graph showing association of pResistin with presence of radio-
graphic knee OA at different levels of pAdiponectin justiﬁed based on statistically
signiﬁcant interaction (P ¼ 0.024). The number of subjects per quartile is indicated on
the x-axis. Error bars represent 95% conﬁdence intervals. OR ¼ 1 is indicated by
a horizontal dotted line. OR/unit, OR per unit increase.
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dence of radiographic knee OA, but these were not corroborated so
much by associations with biochemical markers of joint metabo-
lism and were largely independent of BMI. Although adiponectin
on itself did not show any association with radiographic knee OA,
resistin appeared to be associated with present radiographic knee
OA at higher adiponectin levels only.
We observed some associations between plasma adipokine
levels and urinary and serum biomarker levels. Only a few other
studies have yet investigated associations between adipokines and
biomarkers of cartilage metabolism. Berry et al. looked for cross-
sectional associations between serum adipokine levels and
biomarkers of cartilagemetabolism in 117 knee OA subjects and did
not ﬁnd any statistically signiﬁcant association, nor did they ﬁnd
any association between baseline adipokine levels and 2-year
changes of these biomarkers5. Richette et al. did also not ﬁnd any
association of serum leptin and adiponectinwith PIIANP, COMP, HA,
and HELIX-II levels in 44 knee OA subjects eligible for obesity
surgery15. Since the associations that we observed in 1002 subjects
were only weak, their negative ﬁndings may be due to the smaller
size of their cohorts. Berry et al., however, did in the same study ﬁnd
that baseline soluble leptin-receptor levels were inversely associ-
ated with 2-year changes of PIIANP levels5. Since these soluble
receptors are assumed to decrease leptin activity, this ﬁnding
indirectly corroborates our ﬁndings of leptin being positively
associated with sPIIANP and, may be, sPIIINP. Koskinen et al.
showed a positive association (r ¼ 0.550, P ¼ 0.001, univariate)
between plasma adiponectin levels and serum COMP levels in 35
male knee OA patients undergoing total knee replacement surgery7.
The exceptionally high grade of their association as compared to
ours may be due to the small size of their cohort and/or the end-
stage disease that was present in their subjects. These data from
literature, the weakness of the associations that we found between
adipokine and biomarker levels, and the chance of coincidental
ﬁndings from multiple testing make that the associations that we
found between adipokines and biomarkers of joint metabolism can
not be regarded as strong evidence for a link between adipokines
and joint metabolism. Yet, it should also be emphasized that the
ability of biomarkers to reﬂect actual joint metabolism and their
molecular validity remain to be further elucidated.
The positive associations between leptin, biomarkers of joint
metabolism, and radiographic knee OA measures especiallydisappeared after (additional) adjustment for BMI. This may
suggest that leptin functions as a humoral mediator between fat
mass and OA (i.e., mediation). It may alternatively be that both
leptin and OA progression are positively associated with fat mass,
but that there is no causal relation between leptin and OA them-
selves (i.e., confounding). Moreover, it should be stressed that
cross-sectional associations can only suggest but never prove
causal associations. Interestingly in this respect, Grifﬁn et al.
showed that obesity alone did not cause an increased knee OA
incidence in leptin or leptin receptor knock-out mice16.
The role, if any, of resistin in the pathogenesis of (knee) OA
remains to be further elucidated, but our data suggest that it may
play an aggravating role in human knee OA. Our ﬁndings corrob-
orate with the (weakly) positive associations between serum
resistin levels and histological synovitis scores and synovial TNFa
production that were found in end-stage knee OA patients17. Also,
serum and synovial ﬂuid resistin levels increase after knee injury
and recombinant resistin causes a dose-dependent loss of proteo-
glycans and induction of cytokine production in mouse cartilage
cultures12.
The amount of body fat of CHECK participants needed to be
estimated on the basis of BMI, since other body fat measures were
not available. BMI has been shown to be not only related to fatness
but also lean body mass and to be inﬂuenced by body proportions
(e.g., sitting vs standing height)18 and does not take into account
the possibly protective effect of larger skeletal muscle mass in knee
OA19. Also, more sophisticatedmeasures of body fat (e.g., waistehip
circumference, DXA-assessed total fat mass) have been demon-
strated to have additive value as compared to BMI only20e22. This
may (partly) explain why the associations between plasma resistin
levels and radiographic OA measures were independent of BMI.
Alternatively, it may be that plasma resistin does not function as
a mediator between body fat and OA, but that resistin from some
other source than body fat and/or under control of factors that were
not included in the current study is merely responsible for the
observed associations.
The inﬂammatory properties of adiponectin and its role in OA
have not yet been completely elucidated. On the one hand, adipo-
nectin has been attributed an anti-inﬂammatory, probably
protective, role in knee and hand OA6,8. A contradictory role of
adiponectin and leptin in OAwas suggested by higher synovial ﬂuid
adiponectineleptin ratios being associated with less pain in
60 end-stage knee OA patients23. On the other hand, other studies
have suggested adiponectin to have a pro-inﬂammatory role in OA
based on positive associations with synovial interleukin (IL−1) beta
production in end-stage knee OA patients17 and between hsCRP
and synovial ﬂuid adiponectin in knee OA patients24. In our study
adiponectin showed negative associations with hsCRP levels in
serum, but showed positive associations with markers of cartilage
degradation and appeared to potentiate the association between
resistin and present radiographic knee OA. This inconsistency
between studies may be due to different roles of adiponectin
between blood and synovial ﬂuid, between joints, and between
disease stages.
The positive associations of leptin and resistinwith radiographic
knee OA that we found ﬁt with the hypothesis of OA being a low-
inﬂammatory disease that could be (partly) driven by these pro-
inﬂammatory adipokines. However, all associations were only
weak and were obtained from multiple testing. De Boer et al. also
found only weak associations between serum adipokine levels and
local synovium parameters in 172 end-stage knee OA patients17.
Possibly, humoral associations between adipose tissue and OA, if
any, may especially be relevant in more excessively obese pop-
ulations25 and/or mediated by other routes such as other adipo-
kines than those included in this study26,27, other biologically active
W.E. Van Spil et al. / Osteoarthritis and Cartilage 20 (2012) 1278e12851284forms of the adipokines than detected by the current assays25,28,29,
and/or composition of the lipidome30. Alternatively, intra-
articularly produced adipokines may be more relevant than
systemic adipokines. Honsawek et al. observed negative associa-
tions between plasma adiponectin levels and radiographic knee OA
that disappeared after adjusting for age, gender, and BMI, while
associations of synovial ﬂuid levels of adiponectin persisted after
such adjustment. Apparently, systemic adiponectin levels do not
necessarily reﬂect intra-articular adiponectin production that may
be under control of local conditions6.
Obvious strengths of the current study are its large size, its
5-year longitudinal design, and the large number of adipokines and
biomarkers that were assessed. Of course, this study also has some
limitations. First of all, longitudinal adipokine and biomarker data
assessment would have been preferable over the current cross-
sectional approach but was considered infeasible in its current
size. Second, the early-stage disease of CHECK subjects makes this
cohort valuable, but is not easy to quantify radiographically and
maximum baseline K&L grade per knee was 1. Although K&L grade
1 is by consensus interpreted as doubtful OA, Reijman et al.
demonstrated that 60% of subjects with K&L grade 1 knee OA
developed deﬁnite OA (K&L grade 2) during 10-year follow-up as
compared to 20% of subjects with knee OA grade 012. Moreover,
cross-sectional associations that we found were in line with
predictive associations. Therefore, although the contrast between
healthy and OA joints may not always have been maximum in our
study, we still believe they represent different subpopulations.
Finally, expressing radiographic OA progression as the AUC of
summed K&L grade progression at three time points may look
somewhat unusual. However, this approach was preferred over
absolute progression scores (i.e., summed K&L grade at 5 years
minus baseline) since it distinguishes between early and late
progressors.
In summary, plasma adipokine levels showed weak associations
with biochemical markers of joint metabolism and radiographic
signs of early-stage knee OA. Leptin and resistin showed positive
cross-sectional and predictive associations with radiographic knee
OA, that were especially corroborated by associations with
biochemical markers of systemic joint metabolism for leptin. BMI
appeared to be an important confounder of the associations of
leptin, but could not explain associations of resistin so much. Adi-
ponectin showed positive associations with markers of cartilage
degradation and appeared to potentiate the effects of resistin on
radiographic knee OA, but did not show associations with radio-
graphic knee OA on its own. Altogether this may indicate an
aggravating role of these adipokines in early-stage knee OA,
although a major role could not be demonstrated. More experi-
mental and clinical research of determinants of knee OA and
mediators thereof is needed.
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